Automatic timed dispatch
Bind a calendar item to an approved publishing identity, then publish with idempotency and the same policy check immediately before posting.
Find relevant Threads conversations, preserve the source, prepare work in your own voice, handle a bounded reply inbox, and choose review-first or automatic publishing for immediate actions. Automatic timed dispatch from reserved calendar slots remains a separate milestone.
Available now
Save your goals, topics, content pillars, offers, voice traits, and representative examples. You can review, edit, or remove them at any time.
For You searches saved topics using TOP and RECENT results returned by Meta's Threads API. Search stays bounded to the topics you chose.
Create an original take inspired by a source, or prepare a reply intended for that source. The source snapshot and intended action stay attached to the work item.
Download a plain-language handoff containing the creator context, voice memory, and source as untrusted reference data. The handoff asks for a draft, never automatic publication.
Edit the result before it enters your draft queue. Nothing publishes merely because it was generated or saved.
Work through a bounded inbox that preserves both the incoming reply and your parent post, then save a human-reviewed response draft.
Place a reviewed draft on the calendar in your workspace timezone. You can remove it and schedule it again, but the reservation does not dispatch by itself.
Next product milestone
Bind a calendar item to an approved publishing identity, then publish with idempotency and the same policy check immediately before posting.
Suggest voice traits from official past posts while keeping every inference visible, editable, and removable by the creator.
Feed account observations and creator corrections into the next weekly plan, with no universal score.
Why the distinction is visible
A roadmap is not a feature list. A calendar reservation is not automatic publishing, and creator-entered voice memory is not inferred voice learning. Nothing in the second section is described as available in the current product or included in a trial.